You have 9 free searches left this month | for more free features.

Benserazide, levodopa drug combination

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

Healthy Trial (single-dose madopar, single-dose propranolol, and single-dose by order, single-dose madopar, single-dose , and

Not yet recruiting
  • Healthy
  • single-dose madopar, single-dose propranolol, and single-dose placebo by order
  • +5 more
  • (no location specified)
Sep 13, 2023

Parkinson Disease Trial in Seoul (Levodopa dispersible, Levodopa)

Completed
  • Parkinson Disease
  • Seoul, Korea, Republic of
  • +1 more
May 4, 2021

Parkinson, Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in Sofia (Levodopa Cyclops™, INBRIJA®)

Not yet recruiting
  • Parkinson
  • +2 more
  • Levodopa Cyclops™
  • INBRIJA®
  • Sofia, Bulgaria
    Bed space for short term stay at Diagnostic & Consultative Centr
Sep 13, 2023

Parkinson Disease, Memory Impairment Trial in Beijing (Madopar monotherapy, senfrol monotherapy, monotherapy)

Recruiting
  • Parkinson Disease
  • Memory Impairment
  • Madopar monotherapy
  • +2 more
  • Beijing, China
    Peking University Third Hospital
Jul 8, 2021

Parkinson Disease Trial in Anyang-si (Ongentys 50mg, Madopar Tab. 125 or Perkin Tab. 25-100mg)

Recruiting
  • Parkinson Disease
  • Ongentys 50mg
  • Madopar Tab. 125 or Perkin Tab. 25-100mg
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Hallym University Sacred Heart Hospital
Jun 17, 2021

Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)

Completed
  • Parkinson Disease
  • Standard LD/CD
  • Semi continuous intra-oral administration of LD/CD
  • Rome, Italy
    Irccs San Raffaele Pisana
Oct 17, 2022

Diabetic Retinopathy Trial in Decatur (Sinemet CR, )

Enrolling by invitation
  • Diabetic Retinopathy
  • Sinemet CR
  • placebo
  • Decatur, Georgia
    Atlanta VA Medical and Rehab Center, Decatur, GA
Jul 14, 2022

Stroke Trial in Charlestown (Placebo, Levodopa / Carbidopa, Armeo)

Withdrawn
  • Stroke
  • Placebo
  • +2 more
  • Charlestown, Massachusetts
    Spaulding Rehabilitation Hospital
Dec 17, 2021

Parkinson Disease Trial (Opicapone, L-DOPA/DDCI)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Oct 13, 2021

Depression Trial in Atlanta (Levodopa+carbidopa, Placebo)

Completed
  • Depression
  • Atlanta, Georgia
    Emory University Hospital
Aug 24, 2022

Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

Not yet recruiting
  • Idiopathic Parkinson Disease
  • levodopa/carbidopa oral formulation A
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota
Jul 20, 2022

Reduction of Levodopa and Non-motor Symptoms of Parkinson's

Completed
  • Parkinson Disease
  • Visual Impairment
  • Jinan, Sichuan, China
    Chao Zhang
Jun 4, 2023

Subthalamic Deep Brain Stimulation in Advanced Parkinson's

Active, not recruiting
  • Parkinson Disease
    • Helsinki, Finland
      Department of Neurology and department of Neurosurgery Helsinki
    Oct 18, 2023

    Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)

    Completed
    • Advanced Parkinson's Disease
    • Little Rock, Arkansas
    • +10 more
    May 11, 2022

    Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)

    Recruiting
    • Parkinson Disease
    • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
    • Ahmedabad, Gujarat, India
      Lambda Therapeutic Research Ltd.
    Nov 10, 2021

    Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)

    Suspended
    • Depressive Disorder
    • New York, New York
      New York State Psychiatric Institute
    Jan 26, 2022

    Parkinson's Disease Trial in Amsterdam (Continuous intrajejunal infusion of levodopa-carbidopa, deep brain stimulation)

    Active, not recruiting
    • Parkinson's Disease
    • Continuous intrajejunal infusion of levodopa-carbidopa
    • deep brain stimulation
    • Amsterdam, Noord Holland, Netherlands
      Academic Medical Center
    Apr 20, 2022

    Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)

    Recruiting
    • Chronic Pain
    • Rochester, New York
      University of Rochester Medical Center
    Jan 9, 2023

    Parkinson Disease Trial in Shanghai (WD-1603 Carbidopa-Levodopa Extended-Release Tablets, Placebo)

    Recruiting
    • Parkinson Disease
    • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
    • Placebo
    • Shanghai, Shanghai, China
      Shanghai Huashan Hospital
    Oct 28, 2021

    Levodopa-Induced Dyskinesia, Parkinson's Disease Trial in Tucson (Intervention: Ketamine)

    Active, not recruiting
    • Levodopa-Induced Dyskinesia
    • Parkinson's Disease
    • Intervention: Ketamine
    • Tucson, Arizona
      Scott J Sherman
    Aug 27, 2023

    Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,

    Recruiting
    • Idiopathic Parkinson's Disease
    • PD patients H&Y=1.5-2 Medications ON
    • +4 more
    • Pozzilli, Isernia, Italy
      IRCSS Neuromed Hospital
    May 18, 2022

    Acute Pain, Bunionectomy, Toe Fusion Trial in Chicago (Carbidopa-Levodopa (100mg/25mg):, Naproxen)

    Recruiting
    • Acute Pain
    • +2 more
    • Chicago, Illinois
    • +1 more
    Nov 16, 2021

    AADC/TDC in Advanced Parkinson's Disease

    Not yet recruiting
    • Parkinson Disease
      • (no location specified)
      Dec 9, 2022

      Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

      Recruiting
      • Relapsed/Refractory Follicular Lymphoma
      • Marginal Zone Lymphoma (MZL)
      • Chiang Mai, Thailand
        Chiang Mai University
      Nov 20, 2023